News

Reports of incubators' demise were premature

The University of Cambridge is considering whether to make more cash available to invest in campus spin-off companies. And whatever decision it makes will come in for criticism…

Nuala Moran takes a behind-the-scenes look at the strategies involved in Europe's biggest patent victory in years.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

A team of European researchers is applying a technology used to measure airflow over aircraft wings to improve human heart implants.

With an estimated 400 million people at risk for developing dementia, a natural remedy would be a welcome answer. That's the approach one British company is taking.

Nanonucleant, a spin-out of Imperial College London, is seeking angel financing to move ahead with a glass grain-based technology that aids in crystallising proteins for study as drug targets.

Tracking 15 key technologies, fraud in nanotechnology - and other insights into R&D management

Britain's privatised defence lab ties up with 7 universities, in a strategy to do more with fewer partners.

Not all nanotechnology is hype. Carbon nanotubes are already inside a product near you.